| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/15/2003 | US6592901 Highly compressible ethylcellulose for tableting |
| 07/15/2003 | US6592900 Stabilized polyvinylpyrrolidone formulation |
| 07/15/2003 | US6592899 PLA/PLGA oligomers combined with block copolymers for enhancing solubility of a drug in water |
| 07/15/2003 | US6592897 Slow release tablet prepared from linear water-insoluble polysacchrides |
| 07/15/2003 | US6592895 Biodegradable polyhydric alcohol esters |
| 07/15/2003 | US6592894 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/15/2003 | US6592893 Transdermal patch and topical compositions comprising propylnorapomorphine |
| 07/15/2003 | US6592892 Flushable disposable polymeric products |
| 07/15/2003 | US6592890 Conveyance of anti-infective activity to wound dressings |
| 07/15/2003 | US6592887 Mixture containing water soluble polymer |
| 07/15/2003 | US6592879 Sacrificial enzyme substrate system, an enzyme inhibitor system or mixtures or combinations thereof, where the composition reduces skin irritation due to enzyme activity. |
| 07/15/2003 | US6592868 Produced by hybridoma having ATCC Accession Number HB 10916 |
| 07/15/2003 | US6592860 Composition and applicator for topical substance delivery |
| 07/15/2003 | US6592848 Ready to use aerosol packages |
| 07/15/2003 | US6592847 Intramolecularly-quenched near infrared flourescent probes |
| 07/15/2003 | US6592844 Preparation of protein microspheres, films and coatings |
| 07/15/2003 | US6592843 Liposome mixture containing chelator solution and alpha particle emitting radionuclides; cancer therapy |
| 07/15/2003 | CA2316731C Concentrated and stabilized antipyretic compound for veterinary use to be added to animal feed and process for adding the said compound to animal drinking water |
| 07/15/2003 | CA2122717C Hemoglobins as drug delivery agents |
| 07/10/2003 | WO2003056297A2 Self-assembling polymers, and materials fabricated therefrom |
| 07/10/2003 | WO2003056028A1 Improved method of producing lycopene through the fermentation of selected strains of blakeslea trispora, formulations and uses of the lycopene thus obtained |
| 07/10/2003 | WO2003055935A1 Dendritic poly (amino acid) carriers and methods of use |
| 07/10/2003 | WO2003055917A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 07/10/2003 | WO2003055916A2 Adiponectin fragments and conjugates |
| 07/10/2003 | WO2003055888A1 Hydroxycucurbituril derivatives, their preparation methods and uses |
| 07/10/2003 | WO2003055864A1 Long chain fatty alcohol substituents in antineoplastic agents |
| 07/10/2003 | WO2003055801A1 Low water uptake silicas |
| 07/10/2003 | WO2003055549A1 Metered dose inhaler |
| 07/10/2003 | WO2003055528A2 Amphiphilic compounds for pharmaceutical or cosmetic use |
| 07/10/2003 | WO2003055527A2 Immunoconjugates useful for treatment of tumours |
| 07/10/2003 | WO2003055526A2 Erythropoietin conjugates |
| 07/10/2003 | WO2003055512A1 Liquid composition of factor vii polypeptides |
| 07/10/2003 | WO2003055511A1 Liquid composition of modified factor vii polypeptides |
| 07/10/2003 | WO2003055504A1 Pharmaceutical composition for prevention and treatment of premature ejaculation and/or hypersensitivity of sexual stimulation |
| 07/10/2003 | WO2003055498A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std) |
| 07/10/2003 | WO2003055495A1 ORAL PHARMACEUTICAL PRODUCTS CONTAINING 17β-ESTRADIOL-3-LOWER ALKANOATE, METHOD OF ADMINISTERING THE SAME AND PROCESS OF PREPARATION |
| 07/10/2003 | WO2003055486A1 A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity |
| 07/10/2003 | WO2003055483A1 Famotidine injection |
| 07/10/2003 | WO2003055472A1 Gel comprising at least a retinoid and benzoyl peroxide |
| 07/10/2003 | WO2003055469A1 Improved polymer-lipid delivery vehicles |
| 07/10/2003 | WO2003055468A1 Oral capsule formulation with increased physical stability |
| 07/10/2003 | WO2003055466A1 Microemulsion preconcentrate |
| 07/10/2003 | WO2003055464A1 Micronized pharmaceutical or nutraceutical powder with immediate release |
| 07/10/2003 | WO2003055454A1 New composition |
| 07/10/2003 | WO2003055445A2 Compositions and methods for enhancing corticosteriod delivery |
| 07/10/2003 | WO2003055442A2 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 07/10/2003 | WO2003055324A1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 07/10/2003 | WO2003055323A1 Seal oil based lipid emulsions and uses thereof |
| 07/10/2003 | WO2003039437A3 Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel |
| 07/10/2003 | WO2003037298A3 Bowel cleansing agent |
| 07/10/2003 | WO2003020203A3 Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments |
| 07/10/2003 | WO2003017932A3 Compositions and methods for targeting cerebral circulation and treatment of headache |
| 07/10/2003 | WO2003011227A3 Taste masking composition |
| 07/10/2003 | WO2003008376A3 Adhesive dopa-containing polymers and related methods of use |
| 07/10/2003 | WO2002083060A3 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs |
| 07/10/2003 | WO2002079778A3 In vivo delivery methods and compositions |
| 07/10/2003 | WO2002079394A3 Synthesis and use of glycodendrimer reagents |
| 07/10/2003 | WO2002028408A9 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 07/10/2003 | WO2002026262A3 Compositions for reducing side effects in chemotherapeutic treatments |
| 07/10/2003 | WO2002017962A3 Chemoprotectant for gastric toxicity |
| 07/10/2003 | WO2002009675A9 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release |
| 07/10/2003 | US20030130472 Bioerodible poly (orthoesters)from dioxolane-based diketene acetals |
| 07/10/2003 | US20030130359 Anesthetic comprising sevoflurane, enflurane, isoflurane, methoxyflurane, and/or desflurane stabilized with water, butylated hydroxytoluene, methylparaben, propylparaben, propofol, and thymol |
| 07/10/2003 | US20030130351 Aersol forms of L-3,5,3',5'-tetraiodothyronine; dietetics |
| 07/10/2003 | US20030130341 Taxoids formed by conjugating paclitaxel/docetaxel to polyglutamic acid, polyaspartic acid, or polylysine; antitumor agents; treatment of rheumatoid arthritis and autoimmune diseases |
| 07/10/2003 | US20030130272 Topoisomerase inhibitor; viricides |
| 07/10/2003 | US20030130263 Mixture of two antihistamines; sustained release |
| 07/10/2003 | US20030130252 Process for affecting neurologic progression |
| 07/10/2003 | US20030130248 Topical anti-inflammatory compositions |
| 07/10/2003 | US20030130247 Compositions and methods for enhancing corticosteroid delivery |
| 07/10/2003 | US20030130245 Stabilized aqueous suspensions for parenteral use |
| 07/10/2003 | US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/10/2003 | US20030130231 2:1 Complex of beta- or gamma-cyclodextrin and alpha-tocopherol |
| 07/10/2003 | US20030130214 Proteins, compositions, diagnostic and therapeutic uses thereof |
| 07/10/2003 | US20030130211 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 07/10/2003 | US20030130203 Sleep disorders |
| 07/10/2003 | US20030130193 Controlling cell proliferation, cell differentiation; immobilization |
| 07/10/2003 | US20030130189 Endogenous enzyme to activation drugs; antitumor agents, anticancer agents |
| 07/10/2003 | US20030130178 Water soluble paclitaxel dervatives |
| 07/10/2003 | US20030130170 Water soluble paclitaxel derivatives |
| 07/10/2003 | US20030129678 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 07/10/2003 | US20030129295 Comprises protective lipid coating (hydrogenated oils) for choline chloride or lysine hydrochloride; ruminant feeds |
| 07/10/2003 | US20030129260 Comprising mixture of Western and Chinese herbs which can act as an intestinal bowel soother |
| 07/10/2003 | US20030129251 Polynucleotide of an immunostimulatory sequence linked to a biodegradable microcarrier |
| 07/10/2003 | US20030129249 Preparation of biodegradable, biocompatible microparticles containing a biologically active agent |
| 07/10/2003 | US20030129245 Mixing micronised formoterol its salt or solvate with a pre-micronised carrier/diluent at low energy, agglomerating and spheronisation or adding a coarse carrier/diluent; treating respiratory system disorders |
| 07/10/2003 | US20030129244 Morphine sulfate microgranules, manufacturing process and pharmaceutical preparations |
| 07/10/2003 | US20030129243 Transfection of nucleic acid into a cell and/or organ |
| 07/10/2003 | US20030129242 Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer |
| 07/10/2003 | US20030129241 Effective amount of a vasoactive prostaglandin, a polysaccharide thickener, a lipophilic component, and an acidic buffer system |
| 07/10/2003 | US20030129240 Polyoxyalkylene block copolymer at desired concentrations with or without a therapeutic agent |
| 07/10/2003 | US20030129238 Edible, hardenable, prompt release coating of microcrystalline cellulose (mcc), a film forming propylene glycol alginate (pga), a strengthening polymer and a plasticizer, a surface active agent and a filler |
| 07/10/2003 | US20030129237 Multiparticulate modified release composition |
| 07/10/2003 | US20030129235 Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
| 07/10/2003 | US20030129227 Beta-lactam antibiotic-containing tablet and production thereof |
| 07/10/2003 | US20030129226 Water soluble polymer-based rapidly dissolving tablets and production processes thereof |
| 07/10/2003 | US20030129225 Topical formulations of natamycin/pimaricin |
| 07/10/2003 | US20030129223 Therapeutic agents, comprising a linking carrier, a therapeutic entity associated with the linking carrier, and atleast one targeting entity |
| 07/10/2003 | US20030129221 A mixture of lipids containing a protonatable or deprotonatable lipid, such as polyoxyethylene glycol or polyamide oligomer modified lipid, or amino lipid is combined with a buffered aqueous solution of a charged drug |
| 07/10/2003 | US20030129220 Transdermal administration of androgenic drugs using hydroxide-releasing agents as permeation enhancers |